Jamp-Rehydralyte: Pouch sealing issue that may affect the stability of affected batches.
Last updated
Summary
Product
Jamp-Rehydralyte
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Jamp-Rehydralyte |
Jamp-Rehydralyte |
NPN 80027403 |
Power for Solution |
2-Hydroxy-1,2,3-propanetricarboxylic acid sodium salt (1:3) 530.0 mg / sachet, |
4201 |
Issue
Pouch sealing issue that may affect the stability of affected batches.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products
Companies
Jamp Pharma Corporation
1310 Nobel, Boucherville
Québec, J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-74024
Get notified
Receive notifications for new and updated recalls and alerts by category.